Glenmede Trust’s Phibro Animal Health PAHC Stock Holding History

Glenmede Trust’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-219	Closed	-$3K	–	1935
2020 Q3	$3K	Sell	219 -41	-16%	-$875	﹤0.01%	2201
2020 Q2	$6K	Sell	260 -73	-22%	-$1.81K	﹤0.01%	2037
2020 Q1	$8K	Hold	333	–	–	﹤0.01%	2520
2019 Q4	$8K	Buy	333 +119	+56%	+$2.76K	﹤0.01%	2520
2019 Q3	$4	Hold	214	–	–	﹤0.01%	2713
2019 Q2	$6	Buy	214 +41	+24%	+$1.29K	﹤0.01%	2573
2019 Q1	$5	Hold	173	–	–	﹤0.01%	2617
2018 Q4	$5	Buy	+173	New	+$6.53K	﹤0.01%	2546

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Glenmede Trust's PAHC Position: Q4 2020 in Review

Glenmede Trust sold out of Phibro Animal Health (PAHC) in Q4 2020, closing a stake of 219 shares — an estimated $3K sold.

Glenmede Trust first reported a position in PAHC in Q4 2018 and held it in 8 quarters. The position peaked at $8K in Q1 2020. 136 funds tracked by Wall St. Rank hold PAHC as of Q4 2020.

Glenmede Trust reported no remaining Phibro Animal Health position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 219 Phibro Animal Health shares in Q4 2020, an estimated $3K.
Glenmede Trust first reported a position in Phibro Animal Health in Q4 2018 and held it in 8 quarters.
Glenmede Trust's Phibro Animal Health position peaked at $8K in Q1 2020.
136 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.